window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Research & Development
  • Therapeutic Areas
  • Uncategorised
  • Clinical & Regulatory,Digital & Data

    Pistoia Alliance advances IDMP ontology ahead of EMA medicines data deadline

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics

    Japan approves over-the-counter Cialis as Opella expands access to ED treatment

    read more
  • Clinical & Regulatory,Manufacturing & Supply Chain

    Reacta expands MHRA licence to bring analytical testing in-house

    read more
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development

    CONNECTA starts Phase 2a trial of CTH120 for fragile X syndrome

    read more
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing

    10x Genomics acquires Proteintech Genomics to expand single-cell proteomics capabilities

    read more
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain

    Cellares raises $277M Series D as ARK Invest backs cell therapy manufacturing

    read more
  • Biotech & Pharma Business,Drug Discovery & Development

    AmMax licenses Lonza ADC technology for AML programme

    read more
  • Digital & Data

    UCB adopts Veeva Safety Suite to unify global pharmacovigilance operations

    read more
  • Advanced Therapies,Drug Discovery & Development

    Cartesian licenses WestGene platform to advance in vivo CAR-T for autoimmune diseases

    read more
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Gaelic Laboratories completes first phase of Athlone integration

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE backs AQUIPTA for acute migraine treatment in England and Wales

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    SMC approves TALVEY for relapsed multiple myeloma in Scotland

    read more
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Verdiva Bio unveils obesity drug data ahead of planned clinical entry

    read more
  • Digital & Data,Drug Discovery & Development

    Medable launches programme to support AI deployment in clinical development

    read more
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Sapio Sciences and ZS partner on biopharma laboratory digitalisation

    read more
  • Biotech & Pharma Business,Opinion & Events,Therapeutic Areas

    Chiesi launches second Find For Rare research grants programme at ERA 2026

    read more
Previous101112Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Compass reports second positive Phase 3 trial of psilocybin therapy for treatment-resistant depression
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Healome raises £2M to advance eye-drop technology for ocular surface diseases
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Xeltis completes first commercial implant of aXess haemodialysis device
    Categories: Clinical & Regulatory, Medical devices
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top